Adage Capital Partners Gp, L.L.C. Eli Lilly & CO Transaction History

Adage Capital Partners Gp, L.L.C.

$52.3 Billion
Q2 2024

A detailed history of Adage Capital Partners Gp, L.L.C. transactions in Eli Lilly & CO stock. As of the latest transaction made, Adage Capital Partners Gp, L.L.C. holds 827,681 shares of LLY stock, worth $753 Million. This represents 1.43% of its overall portfolio holdings.

Number of Shares

827,681

Previous 829,080 0.17%

Holding current value

$753 Million

Previous $645 Million 16.18%

% of portfolio

1.43%

Previous 1.26%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$724.87 - $909.04 $1.01 Million - $1.27 Million	-1,399 Reduced 0.17%	827,681 $749 Million
Q1 2024 May 15, 2024	SELL	$592.2 - $792.28 $56.4 Million - $75.4 Million	-95,208 Reduced 10.3%	829,080 $645 Million
Q4 2023 Feb 14, 2024	SELL	$525.19 - $619.13 $17.8 Million - $21 Million	-33,842 Reduced 3.53%	924,288 $539 Million
Q3 2023 Nov 14, 2023	BUY	$434.7 - $599.3 $9.87 Million - $13.6 Million	22,710 Added 2.43%	958,130 $515 Million
Q2 2023 Aug 14, 2023	SELL	$350.74 - $468.98 $88.7 Million - $119 Million	-252,773 Reduced 21.27%	935,420 $439 Million
Q1 2023 May 15, 2023	BUY	$310.63 - $364.82 $64.2 Million - $75.4 Million	206,551 Added 21.04%	1,188,193 $408 Million
Q4 2022 Feb 14, 2023	BUY	$321.55 - $374.67 $26.6 Million - $31 Million	82,765 Added 9.21%	981,642 $359 Million
Q3 2022 Nov 14, 2022	SELL	$296.48 - $337.87 $64.6 Million - $73.6 Million	-217,791 Reduced 19.5%	898,877 $291 Million
Q2 2022 Aug 15, 2022	BUY	$278.73 - $327.27 $37.3 Million - $43.8 Million	133,910 Added 13.63%	1,116,668 $362 Million
Q1 2022 May 16, 2022	SELL	$234.69 - $291.66 $5.87 Million - $7.29 Million	-25,000 Reduced 2.48%	982,758 $281 Million
Q4 2021 Feb 14, 2022	SELL	$224.85 - $279.04 $38.1 Million - $47.3 Million	-169,408 Reduced 14.39%	1,007,758 $278 Million
Q3 2021 Nov 15, 2021	BUY	$221.6 - $272.71 $81 Million - $99.7 Million	365,640 Added 45.06%	1,177,166 $272 Million
Q2 2021 Aug 16, 2021	SELL	$180.55 - $233.54 $12.4 Million - $16.1 Million	-68,812 Reduced 7.82%	811,526 $186 Million
Q1 2021 May 17, 2021	BUY	$164.32 - $212.72 $79.3 Million - $103 Million	482,487 Added 121.27%	880,338 $164 Million
Q4 2020 Feb 16, 2021	BUY	$130.46 - $172.63 $8.35 Million - $11 Million	64,000 Added 19.17%	397,851 $67.2 Million
Q3 2020 Nov 16, 2020	BUY	$146.22 - $169.13 $17.7 Million - $20.5 Million	121,200 Added 56.99%	333,851 $49.4 Million
Q2 2020 Aug 14, 2020	SELL	$136.42 - $164.18 $89.4 Million - $108 Million	-655,400 Reduced 75.5%	212,651 $34.9 Million
Q1 2020 May 15, 2020	BUY	$119.05 - $147.35 $77 Million - $95.3 Million	646,490 Added 291.79%	868,051 $120 Million
Q4 2019 Feb 14, 2020	SELL	$106.92 - $132.43 $21 Million - $26 Million	-196,700 Reduced 47.03%	221,561 $29.1 Million
Q3 2019 Nov 14, 2019	BUY	$106.79 - $116.16 $6.99 Million - $7.61 Million	65,500 Added 18.57%	418,261 $46.8 Million
Q2 2019 Aug 14, 2019	SELL	$110.79 - $129.32 $80.6 Million - $94.1 Million	-727,345 Reduced 67.34%	352,761 $39.1 Million
Q1 2019 May 15, 2019	SELL	$111.31 - $131.02 $12.6 Million - $14.8 Million	-113,019 Reduced 9.47%	1,080,106 $140 Million
Q4 2018 Feb 14, 2019	SELL	$105.9 - $118.64 $3.51 Million - $3.94 Million	-33,190 Reduced 2.71%	1,193,125 $138 Million
Q3 2018 Nov 14, 2018	SELL	$85.86 - $107.31 $38 Million - $47.5 Million	-443,075 Reduced 26.54%	1,226,315 $132 Million
Q2 2018 Aug 14, 2018	BUY	$75.7 - $86.88 $5.75 Million - $6.6 Million	75,990 Added 4.77%	1,669,390 $142 Million
Q1 2018 May 15, 2018	SELL	$74.21 - $87.6 $6.22 Million - $7.35 Million	-83,870 Reduced 5.0%	1,593,400 $123 Million
Q4 2017 Feb 14, 2018	BUY	$81.94 - $87.89 $23.8 Million - $25.6 Million	290,775 Added 20.97%	1,677,270 $142 Million
Q3 2017 Nov 14, 2017	BUY	$77.07 - $85.54 $107 Million - $119 Million	1,386,495	1,386,495 $119 Million

Others Institutions Holding LLY

# of Institutions

3,887

Shares Held

763M

Call Options Held

6.34M

Put Options Held

7.97M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $864B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Adage Capital Partners Gp, L.L.C., based on Form 13F filings with the SEC.

News

Stay updated on Adage Capital Partners Gp, L.L.C. with notifications on news.

Account

Adage Capital Partners Gp, L.L.C. Eli Lilly & CO Transaction History